Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107479 · ClinicalTrials.gov registry record · NA
Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 8,959
- Enrollment target
NCT05107479: Completed NA study, sponsored by Stanford University.
NCT05107479 is a NA study that has completed, run by Stanford University. The registered enrollment target is 8,959 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (539% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05107479, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,959 participants
- Enrollment target
Study Summary
This study seeks to evaluate the effectiveness of a remote training course delivered via interactive voice response (IVR) to the mobile phones of frontline providers in the Democratic Republic of the Congo (DRC) during the COVID-19 pandemic. The randomized trial will examine the impact of the training on health workers' knowledge, beliefs and intended behaviors related to COVID-19 vaccines and vaccine administration. Potential enrollees will be consented first, after which the participants assigned to the treatment group will be invited to participate in the training over a one month period, while the control group will receive the intervention following a month delay, which will allow for the comparison of knowledge and beliefs with a group that is controlled for bias introduced by time. We hypothesize that the training will lead to increased knowledge about vaccines, lower vaccine hesitancy, and increased preparedness to administer vaccines among trained health workers.
Primary Outcome
Standardized score on an assessment of 10 knowledge questions about COVID-19 vaccines and vaccine administration, drawn directly from the IVR curriculum
Interventions
- BEHAVIORAL Control Condition
- BEHAVIORAL COVID-19 Vaccine IVR Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,959 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2022-02-10 |
| Phase | NA |
What the finished NCT05107479 record still lists
NCT05107479 is an interventional study that assigns participants to a tested intervention. Its 8,959 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (539% higher).
The record links to 0 conditions, and to 2 interventions - of which Control Condition is the first listed.
NCT05107479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05107479 about?
NCT05107479 is a clinical study titled "Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo". This study seeks to evaluate the effectiveness of a remote training course delivered via interactive voice response (IVR) to the mobile phones of frontline providers in the Democratic Republic of the Congo (DRC) during the COVID-19 pandemic. The randomized trial will examine the impact of the traini...
What is the current status of trial NCT05107479?
This trial is currently completed. It is a NA study. The enrollment target is 8,959 participants. The study started on 2021-11-09. Estimated completion is 2022-02-10.
What interventions are being tested in trial NCT05107479?
The interventions under investigation include: Control Condition (BEHAVIORAL), COVID-19 Vaccine IVR Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05107479?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05107479's enrollment target sits among peer trials
8,959 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI